Literature DB >> 6307551

Adrenal abnormalities in idiopathic hirsutism.

A Moore, F Magee, S Cunningham, M Culliton, T J McKenna.   

Abstract

The possibility that abnormal adrenal androgen production may be present in patients with idiopathic hirsutism was examined. Plasma testosterone, dihydrotestosterone and androstenedione levels were elevated in hirsute patients. In response to exogenous alpha 1-24 ACTH the increments in plasma androstenedione, dehydroepiandrosterone (DHA) and cortisol were significantly greater in hirsute patients than in normal subjects. The testosterone response was exaggerated following endogenous stimulation induced by metyrapone. Treatment with dexamethasone, 0.5 mg each night for 3 months, corrected both the androgen excess and the exaggerated androgen responses but not the excessive cortisol response to stimulation. These observations indicate adrenal abnormalities in idiopathic hirsutism. The dissociation of cortisol and adrenal androgen responsiveness following dexamethasone suggests that the abnormalities observed may be due to excessive adrenal androgen production stimulated by a dexamethasone-suppressible factor other than ACTH. Excess adrenal androgen production may be the primary disorder leading to the development of idiopathic hirsutism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307551     DOI: 10.1111/j.1365-2265.1983.tb00584.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

Review 1.  Hirsutism: common clinical problem or index of serious disease?

Authors:  Oguz Tekin; Zekai Avci; Bünyamin Isik; Adem Ozkara; Cem Uraldi; Ferhat Catal; Elife Eraslan; Tuncay Delibasi
Journal:  MedGenMed       Date:  2004-10-15

2.  Common sex hormone abnormalities in women.

Authors:  T J McKenna
Journal:  Ir J Med Sci       Date:  1985-04       Impact factor: 1.568

3.  Plasma pro-opiomelanocortin fragments and adrenal steroids following administration of metyrapone to normal and hirsute women.

Authors:  S K Cunningham; T Loughlin; X Bertagna; F Girard; T J McKenna
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

4.  [Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate].

Authors:  K Frank-Raue; G Junga; F Raue; P Vecsei; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-06-19

5.  A role for a non-androgenic anovulant in the management of hirsutism.

Authors:  T J McKenna; S K Cunningham
Journal:  Ir J Med Sci       Date:  1991-07       Impact factor: 1.568

Review 6.  Endocrine evaluation of hirsutism.

Authors:  John Mihailidis; Racha Dermesropian; Pamela Taxel; Pooja Luthra; Jane M Grant-Kels
Journal:  Int J Womens Dermatol       Date:  2015-06-04

Review 7.  Endocrine evaluation of hirsutism.

Authors:  John Mihailidis; Racha Dermesropian; Pamela Taxel; Pooja Luthra; Jane M Grant-Kels
Journal:  Int J Womens Dermatol       Date:  2017-02-16

8.  The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism

Authors:  Taner Demirci; Hasret Cengiz; Ceyhun Varım; Sedat Çetin
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.